ENvue Medical, Inc.
FEED- Exchange
- OTC
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001326706
No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in ENvue Medical, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −8 vs. Q4 2022
- Shares held
- 59.5K
- −58.9K (−49.8%) vs. Q4 2022Converted for a 1-for-20 split
- Total value
- $203.6K
- −$389.4K (−65.7%) vs. Q4 2022
- New holders
- 1
- 4 more added
- Sold out
- 9
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FEED on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $149.2K |
| Q1 2026 | 13 | $179.2K |
| Q4 2025 | 6 | $42.5K |
| Q3 2025 | 6 | $9.50K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 9 | $215.3K |
| Q3 2024 | 9 | $251.5K |
| Q2 2024 | 8 | $163.3K |
| Q1 2024 | 10 | $327.2K |
| Q4 2023 | 11 | $123.0K |
| Q3 2023 | 13 | $242.1K |
| Q2 2023 | 9 | $142.1K |
| Q1 2023 | 10 | $203.6K |
| Q4 2022 | 18 | $593.0K |
| Q3 2022 | 15 | $679.0K |
| Q2 2022 | 13 | $906.0K |
| Q1 2022 | 19 | $2.12M |
| Q4 2021 | 20 | $1.72M |
| Q3 2021 | 21 | $2.60M |
| Q2 2021 | 17 | $954.1K |
| Q1 2021 | 14 | $1.17M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding ENvue Medical, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 31,682 | $108.7K | 0.00% | −903−2.8% | ReducedConverted for a 1-for-20 split |
| Amtrust Financial Services, Inc. | 12,407 | $42.6K | 0.02% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Geode Capital Management, LLC | 10,721 | $36.2K | 0.00% | −201−1.8% | ReducedConverted for a 1-for-20 split |
| UBS Group AG | 3,669 | $12.6K | 0.00% | +3,206+692.6% | AddedConverted for a 1-for-20 split |
| Tower Research Capital LLC (TRC) | 806 | $3.00K | 0.00% | +806 | New |
| BlackRock Inc. | 74 | $254 | 0.00% | +1+1.0% | AddedConverted for a 1-for-20 split |
| Bank of America Corp | 64 | $220 | 0.00% | +61+1,839.4% | AddedConverted for a 1-for-20 split |
| Wells Fargo & Company | 11 | $38 | 0.00% | +1+15.2% | AddedConverted for a 1-for-20 split |
| Morgan Stanley | 10 | $34 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| NewSquare Capital LLC | 10 | $34 | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −45,053−100.0% | Sold outConverted for a 1-for-20 split |
| State Street Corp | 0 | $0 | 0.00% | −6,270−100.0% | Sold outConverted for a 1-for-20 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,808−100.0% | Sold outConverted for a 1-for-20 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −2,730−100.0% | Sold outConverted for a 1-for-20 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −2,343−100.0% | Sold outConverted for a 1-for-20 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −816−100.0% | Sold outConverted for a 1-for-20 split |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −718−100.0% | Sold outConverted for a 1-for-20 split |
| StoneX Group Inc. | 0 | $0 | 0.00% | −620−100.0% | Sold outConverted for a 1-for-20 split |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −486−100.0% | Sold outConverted for a 1-for-20 split |